Creatus Announces Patent Issuance, Close of Financing and Pilot Demonstration in 2019 Year Review

with No Comments

Vancouver, Canada, January 27, 2020 – Creatus Biosciences Inc. (Creatus), announced today in its 2019 year review that it has received issuance of a core patent related to its Xylitol Bioproduction System by the US Patent Office. The company also announced that it closed a US $1.5m financing and achieved pilot scale demonstration of its Xylitol Bioproduction System at an independent contract research organization…

Download Release